Abstract
Virotherapy is an approach for the treatment of cancer, in which the replicating virus itself is the anticancer agent. Virotherapy exploits the lytic property of virus replication to kill tumor cells. As this approach relies on viral replication, the virus can self-amplify and spread in the tumor from an initial infection of only a few cells. The success of this approach is fundamentally based on the ability to deliver the replication-competent viral genome to target cells with a requisite level of efficiency. With virotherapy, while a number of transcriptional retargeting strategies have been utilized to restrict viral replication to tumor cells, this review will focus primarily on transductional retargeting strategies, whereby oncolytic viruses can be designed to selectively infect tumor cells. Using the adenoviral vector paradigm, there are three broad strategies useful for viral retargeting. One strategy uses heterologous retargeting ligands that are bispecific in that they bind both to the viral vector as well as to a cell surface target. A second strategy uses genetically modified viral vectors in which a cellular retargeting ligand is incorporated. A third strategy involves the construction of chimeric recombinant vectors, in which a capsid protein from one virus is exchanged for that of another. These transductional retargeting strategies have the potential for reducing deleterious side effects, and increasing the therapeutic index of virotherapeutic agents.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adachi Y, Reynolds PN, Yamamoto M, Wang M, Takayama K, Matsubara S, Muramatsu T and Curiel DT . (2001). Cancer Res., 61, 7882–7888.
Akalu A, Liebermann H, Bauer U, Granzow H and Seidel W . (1999). J. Virol., 73, 6182–6187.
Alemany R, Balague C and Curiel DT . (2000a). Nat. Biotechnol., 18, 723–727.
Alemany R and Curiel DT . (2001). Gene Therapy, 8, 1347–1353.
Alemany R, Suzuki K and Curiel DT . (2000b). J. Gen. Virol., 81, 2605–2609.
Anderson BD, Nakamura T, Russell SJ and Peng KW . (2004). Cancer Res., 64, 4919–4926.
Arai T, Matsumoto K, Saitoh K, Ui M, Ito T, Murakami M, Kanegae Y, Saito I, Cosset FL, Takeuchi Y and Iba H . (1998). J. Virol., 72, 1115–1121.
Arnberg N, Edlund K, Kidd AH and Wadell G . (2000). J. Virol., 74, 42–48.
Arnberg N, Kidd AH, Edlund K, Nilsson J, Pring-Akerblom P and Wadell G . (2002). Virology, 302, 33–43.
Asaoka K, Tada M, Sawamura Y, Ikeda J and Abe H . (2000). J. Neurosurg., 92, 1002–1008.
Atkins GJ, Smyth JW, Fleeton MN, Galbraith SE and Sheahan BJ . (2004). Curr. Cancer Drug Targets, 4, 597–607.
Banerjee NS, Rivera AA, Wang M, Chow LT, Broker TR, Curiel DT and Nettelbeck DM . (2004). Mol. Cancer Ther., 3, 437–449.
Barker SD, Dmitriev IP, Nettelbeck DM, Liu B, Rivera AA, Alvarez RD, Curiel DT and Hemminki A . (2003). Gene Therapy, 10, 1198–1204.
Baxi MK, Deregt D, Robertson J, Babiuk LA, Schlapp T and Tikoo SK . (2000). Virology, 278, 234–243.
Belousova N, Korokhov N, Krendelshchikova V, Simonenko V, Mikheeva G, Triozzi PL, Aldrich WA, Banerjee PT, Gillies SD, Curiel DT and Krasnykh V . (2003). J. Virol., 77, 11367–11377.
Belousova N, Krendelchtchikova V, Curiel DT and Krasnykh V . (2002). J. Virol., 76, 8621–8631.
Bennett JJ, Tjuvajev J, Johnson P, Doubrovin M, Akhurst T, Malholtra S, Hackman T, Balatoni J, Finn R, Larson SM, Federoff H, Blasberg R and Fong Y . (2001). Nat. Med., 7, 859–863.
Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL and Finberg RW . (1997). Science, 275, 1320–1323.
Bergelson JM, Krithivas A, Celi L, Droguett G, Horwitz MS, Wickham T, Crowell RL and Finberg RW . (1998). J. Virol., 72, 415–419.
Bhaumik S and Gambhir SS . (2002). Proc. Natl. Acad. Sci. USA, 99, 377–382.
Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A and McCormick F . (1996). Science, 274, 373–376.
Blackwell JL, Li H, Gomez-Navarro J, Dmitriev I, Krasnykh V, Richter CA, Shaw DR, Alvarez RD, Curiel DT and Strong TV . (2000). Hum. Gene Ther., 11, 1657–1669.
Blackwell JL, Miller CR, Douglas JT, Li H, Reynolds PN, Carroll WR, Peters GE, Strong TV and Curiel DT . (1999). Arch. Otolaryngol. Head Neck Surg., 125, 856–863.
Borovjagin AV, Krendelchtchikov A, Ramesh N, Yu DC, Douglas JT and Curiel DT . (2005). Cancer Gene Ther., 12, 475–486.
Breidenbach M, Rein DT, Wang M, Nettelbeck DM, Hemminki A, Ulasov I, Rivera AR, Everts M, Alvarez RD, Douglas JT and Curiel DT . (2004). Hum. Gene Ther., 15, 509–518.
Brunetti-Pierri N, Palmer DJ, Beaudet AL, Carey KD, Finegold M and Ng P . (2004). Hum. Gene Ther., 15, 35–46.
Buller RE, Runnebaum IB, Karlan BY, Horowitz JA, Shahin M, Buekers T, Petrauskas S, Kreienberg R, Slamon D and Pegram M . (2002). Cancer Gene Ther., 9, 553–566.
Cashman SM, Morris DJ and Kumar-Singh R . (2004). Virology, 324, 129–139.
Chen J, Reeves L and Cornetta K . (2001). Hum. Gene Ther., 12, 61–70.
Chen J, Zajac AJ, McPherson SA, Hsu HC, Yang P, Wu Q, Xu X, Wang X, Fujihashi K, Curiel DT and Mountz JD . (2005). Gene Therapy, 12, 1079–1088.
Cherenova LV, Logunov DY, Shashkova EV, Shmarov MM, Verkhovskaya LV, Neugodova GL, Kazansky DB, Doronin KK and Naroditsky BS . (2004). Virus Res., 100, 257–261.
Chiocca EA, Abbed KM, Tatter S, Louis DN, Hochberg FH, Barker F, Kracher J, Grossman SA, Fisher JD, Carson K, Rosenblum M, Mikkelsen T, Olson J, Markert J, Rosenfeld S, Nabors LB, Brem S, Phuphanich S, Freeman S, Kaplan R and Zwiebel J . (2004). Mol. Ther., 10, 958–966.
Cho JY, Shen DH, Yang W, Williams B, Buckwalter TL, La Perle KM, Hinkle G, Pozderac R, Kloos R, Nagaraja HN, Barth RF and Jhiang SM . (2002). Gene Therapy, 9, 1139–1145.
Christ M, Louis B, Stoeckel F, Dieterle A, Grave L, Dreyer D, Kintz J, Ali Hadji D, Lusky M and Mehtali M . (2000). Hum. Gene Ther., 11, 415–427.
Colby WW and Shenk T . (1981). J. Virol., 39, 977–980.
Cosset FL and Russell SJ . (1996). Gene Therapy, 3, 946–956.
Cripe TP, Dunphy EJ, Holub AD, Saini A, Vasi NH, Mahller YY, Collins MH, Snyder JD, Krasnykh V, Curiel DT, Wickham TJ, DeGregori J, Bergelson JM and Currier MA . (2001). Cancer Res., 61, 2953–2960.
Csatary LK, Gosztonyi G, Szeberenyi J, Fabian Z, Liszka V, Bodey B and Csatary CM . (2004). J. Neurooncol., 67, 83–93.
Curiel DT and Douglas JT (eds) (2002). Adenoviral Vectors for Gene Therapy. Academic Press: New York.
Curtis R and Barnett KC . (1983). Vet. Rec., 112, 347–353.
Davydova J, Le LP, Gavrikova T, Wang M, Krasnykh V and Yamamoto M . (2004). Cancer Res., 64, 4319–4327.
Denby L, Work LM, Graham D, Hsu C, von Seggern DJ, Nicklin SA and Baker AH . (2004). Hum. Gene Ther., 15, 1054–1064.
Devaux C, Adrian M, Berthet-Colominas C, Cusack S and Jacrot B . (1990). J. Mol. Biol., 215, 567–588.
DeWeese TL, van der Poel H, Li S, Mikhak B, Drew R, Goemann M, Hamper U, DeJong R, Detorie N, Rodriguez R, Haulk T, DeMarzo AM, Piantadosi S, Yu DC, Chen Y, Henderson DR, Carducci MA, Nelson WG and Simons JW . (2001). Cancer Res., 61, 7464–7472.
Dingli D, Peng KW, Harvey ME, Greipp PR, O'Connor MK, Cattaneo R, Morris JC and Russell SJ . (2004). Blood, 103, 1641–1646.
Dirven CM, Grill J, Lamfers ML, Van der Valk P, Leonhart AM, Van Beusechem VW, Haisma HJ, Pinedo HM, Curiel DT, Vandertop WP and Gerritsen WR . (2002). J. Neurosurg., 97, 441–449.
Dmitriev I, Kashentseva E, Rogers BE, Krasnykh V and Curiel DT . (2000). J. Virol., 74, 6875–6884.
Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G, Belousova N and Curiel DT . (1998a). J. Virol., 72, 9706–9713.
Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G, Belousova N and Curiel DT . (1998b). J. Virol., 72, 9706–9713.
Dmitriev IP, Kashentseva EA and Curiel DT . (2002). J. Virol., 76, 6893–6899.
Doronin K, Toth K, Kuppuswamy M, Ward P, Tollefson AE and Wold WS . (2000). J. Virol., 74, 6147–6155.
Douglas JT, Rogers BE, Rosenfeld ME, Michael SI, Feng M and Curiel DT . (1996). Nat. Biotechnol., 14, 1574–1578.
Ebert O, Harbaran S, Shinozaki K and Woo SL . (2005). Cancer Gene Ther., 12, 350–358.
Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, Wingo PA, Jemal A and Feigal EG . (2002). Cancer, 94, 2766–2792.
Einfeld DA, Brough DE, Roelvink PW, Kovesdi I and Wickham TJ . (1999). J. Virol., 73, 9130–9136.
Everett RS, Hodges BL, Ding EY, Xu F, Serra D and Amalfitano A . (2003). Hum. Gene Ther., 14, 1715–1726.
Everts M, Kim-Park SA, Preuss MA, Passineau MJ, Glasgow JN, Pereboev AV, Mahasreshti PJ, Grizzle WE, Reynolds PN and Curiel DT . (2005). Gene Therapy, 12, 1042–1048.
Farina SF, Gao GP, Xiang ZQ, Rux JJ, Burnett RM, Alvira MR, Marsh J, Ertl HC and Wilson JM . (2001). J. Virol., 75, 11603–11613.
Freytag SO, Khil M, Stricker H, Peabody J, Menon M, DePeralta-Venturina M, Nafziger D, Pegg J, Paielli D, Brown S, Barton K, Lu M, Aguilar-Cordova E and Kim JH . (2002). Cancer Res., 62, 4968–4976.
Freytag SO, Stricker H, Pegg J, Paielli D, Pradhan DG, Peabody J, DePeralta-Venturina M, Xia X, Brown S, Lu M and Kim JH . (2003). Cancer Res., 63, 7497–7506.
Fueyo J, Gomez-Manzano C, Alemany R, Lee PS, McDonnell TJ, Mitlianga P, Shi YX, Levin VA, Yung WK and Kyritsis AP . (2000). Oncogene, 19, 2–12.
Fuxe J, Liu L, Malin S, Philipson L, Collins VP and Pettersson RF . (2003). Int. J. Cancer, 103, 723–729.
Galanis E, Okuno SH, Nascimento AG, Lewis BD, Lee RA, Oliveira AM, Sloan JA, Atherton P, Edmonson JH, Erlichman C, Randlev B, Wang Q, Freeman S and Rubin J . (2005). Gene Therapy, 12, 437–445.
Galanis E and Russell S . (2001). Br. J. Cancer, 85, 1432–1436.
Gall J, Kass-Eisler A, Leinwand L and Falck-Pedersen E . (1996). J. Virol., 70, 2116–2123.
Ganly I, Kim YT, Hann B, Balmain A and Brown R . (2001). Gene Therapy, 8, 369–375.
Ganly I, Kirn D, Eckhardt G, Rodriguez GI, Soutar DS, Otto R, Robertson AG, Park O, Gulley ML, Heise C, Von Hoff DD, Kaye SB and Eckhardt SG . (2000). Clin. Cancer Res., 6, 798–806.
Geoerger B, Grill J, Opolon P, Morizet J, Aubert G, Lecluse Y, van Beusechem VW, Gerritsen WR, Kirn DH and Vassal G . (2003). Br. J. Cancer, 89, 577–584.
Glasgow JN, Kremer EJ, Hemminki A, Siegal GP, Douglas JT and Curiel DT . (2004). Virology, 324, 103–116.
Glotzer JB, Michou AI, Baker A, Saltik M and Cotten M . (2001). J. Virol., 75, 2421–2434.
Goldman CK, Rogers BE, Douglas JT, Sosnowski BA, Ying W, Siegal GP, Baird A, Campain JA and Curiel DT . (1997). Cancer Res., 57, 1447–1451.
Goossens PH, Havenga MJ, Pieterman E, Lemckert AA, Breedveld FC, Bout A and Huizinga TW . (2001). Arthritis Rheum., 44, 570–577.
Grill J, Van Beusechem VW, Van Der Valk P, Dirven CM, Leonhart A, Pherai DS, Haisma HJ, Pinedo HM, Curiel DT and Gerritsen WR . (2001). Clin. Cancer Res., 7, 641–650.
Gruber WC, Russell DJ and Tibbetts C . (1993). Virology, 196, 603–611.
Habib N, Salama H, Abd El Latif Abu Median A, Isac Anis I, Abd Al Aziz RA, Sarraf C, Mitry R, Havlik R, Seth P, Hartwigsen J, Bhushan R, Nicholls J and Jensen S . (2002). Cancer Gene Ther., 9, 254–259.
Haisma HJ, Grill J, Curiel DT, Hoogeland S, van Beusechem VW, Pinedo HM and Gerritsen WR . (2000). Cancer Gene Ther., 7, 901–904.
Hallden G, Hill R, Wang Y, Anand A, Liu TC, Lemoine NR, Francis J, Hawkins L and Kirn D . (2003). Mol. Ther., 8, 412–424.
Hallenbeck PL, Chang YN, Hay C, Golightly D, Stewart D, Lin J, Phipps S and Chiang YL . (1999). Hum. Gene Ther., 10, 1721–1733.
Hammond JM and Johnson MA . (2005). Vet. J., 169, 17–27.
Harada JN and Berk AJ . (1999). J. Virol., 73, 5333–5344.
Harrow S, Papanastassiou V, Harland J, Mabbs R, Petty R, Fraser M, Hadley D, Patterson J, Brown SM and Rampling R . (2004). Gene Therapy, 11, 1648–1658.
Haviv YS, Blackwell JL, Kanerva A, Nagi P, Krasnykh V, Dmitriev I, Wang M, Naito S, Lei X, Hemminki A, Carey D and Curiel DT . (2002). Cancer Res., 62, 4273–4281.
Hay JG, Shapiro N, Sauthoff H, Heitner S, Phupakdi W and Rom WN . (1999). Hum. Gene Ther., 10, 579–590.
Hay JG . (2004). Trends Biotechnol., 22, 501–503.
Hedley SJ, Auf der Maur A, Hohn S, Escher D, Barberis A, Douglas JT, Korokhov N and Curiel DT . (2005). Gene Therapy (in press).
Heinzerling L, Kunzi V, Oberholzer PA, Kundig T, Naim H and Dummer R . (2005). Blood, June 16 (Epub ahead of print).
Hemmi S, Geertsen R, Mezzacasa A, Peter I and Dummer R . (1998). Hum. Gene Ther., 9, 2363–2373.
Hemminki A, Belousova N, Zinn KR, Liu B, Wang M, Chaudhuri TR, Rogers BE, Buchsbaum DJ, Siegal GP, Barnes MN, Gomez-Navarro J, Curiel DT and Alvarez RD . (2001). Mol. Ther., 4, 223–231.
Henning P, Andersson KM, Frykholm K, Ali A, Magnusson MK, Nygren PA, Granio O, Hong SS, Boulanger P and Lindholm L . (2005). Gene Therapy, 12, 211–224.
Henry LJ, Xia D, Wilke ME, Deisenhofer J and Gerard RD . (1994). J. Virol., 68, 5239–5246.
Herrero YCM, Cornelis JJ, Herold-Mende C, Rommelaere J, Schlehofer JR and Geletneky K . (2004). Int. J. Cancer, 109, 76–84.
Herschman HR . (2004). Adv. Cancer Res., 92, 29–80.
Hong JS and Engler JA . (1996). J. Virol., 70, 7071–7078.
Hong SS, Karayan L, Tournier J, Curiel DT and Boulanger PA . (1997). EMBO J., 16, 2294–2306.
Hu J, Kelly P, Bonifacino A, Agricola B, Donahue R, Vanin E and Dunbar CE . (2003). Mol. Ther. J. Am. Soc. Gene Ther., 8, 611–617.
Irving J, Wang Z, Powell S, O'Sullivan C, Mok M, Murphy B, Cardoza L, Lebkowski JS and Majumdar AS . (2004). Cancer Gene Ther., 11, 174–185.
Itoh A, Okada T, Mizuguchi H, Hayakawa T, Mizukami H, Kume A, Takatoku M, Komatsu N, Hanazono Y and Ozawa K . (2003). J. Gene Med., 5, 929–940.
Joung I, Harber G, Gerecke KM, Carroll SL, Collawn JF and Engler JA . (2005). Biochem. Biophys. Res. Commun., 328, 1182–1187.
Kanerva A, Bauerschmitz GJ, Yamamoto M, Lam JT, Alvarez RD, Siegal GP, Curiel DT and Hemminki A . (2004). Gene Therapy, 11, 552–559.
Kanerva A, Mikheeva GV, Krasnykh V, Coolidge CJ, Lam JT, Mahasreshti PJ, Barker SD, Straughn M, Barnes MN, Alvarez RD, Hemminki A and Curiel DT . (2002). Clin. Cancer Res., 8, 275–280.
Kanerva A, Zinn KR, Peng KW, Ranki T, Kangasniemi L, Chaudhuri TR, Desmond RA, Wang M, Takayama K, Hakkarainen T, Alfthan H, Stenman UH, Curiel DT and Hemminki A . (2005). Gene Therapy, 12, 87–94.
Kashentseva EA, Seki T, Curiel DT and Dmitriev IP . (2002). Cancer Res., 62, 609–616.
Kawakami Y, Li H, Lam JT, Krasnykh V, Curiel DT and Blackwell JL . (2003). Cancer Res., 63, 1262–1269.
Kawashima H, Ogose A, Yoshizawa T, Kuwano R, Hotta Y, Hotta T, Hatano H and Endo N . (2003). Cancer Sci., 94, 70–75.
Kelly FJ, Miller CR, Buchsbaum DJ, Gomez-Navarro J, Barnes MN, Alvarez RD and Curiel DT . (2000). Clin. Cancer Res., 6, 4323–4333.
Khuri FR, Nemunaitis J, Ganly I, Arseneau J, Tannock IF, Romel L, Gore M, Ironside J, MacDougall RH, Heise C, Randlev B, Gillenwater AM, Bruso P, Kaye SB, Hong WK and Kirn DH . (2000). Nat. Med., 6, 879–885.
Kim J, Smith T, Idamakanti N, Mulgrew K, Kaloss M, Kylefjord H, Ryan PC, Kaleko M and Stevenson SC . (2002a). J. Virol., 76, 1892–1903.
Kim M, Sumerel LA, Belousova N, Lyons GR, Carey DE, Krasnykh V and Douglas JT . (2003). Br. J. Cancer, 88, 1411–1416.
Kim M, Zinn KR, Barnett BG, Sumerel LA, Krasnykh V, Curiel DT and Douglas JT . (2002b). Eur. J. Cancer, 38, 1917–1926.
Kim SH, Wong RJ, Kooby DA, Carew JF, Adusumilli PS, Patel SG, Shah JP and Fong Y . (2005). Eur. J. Cancer, 41, 313–322.
Kirby TO, Rivera A, Rein D, Wang M, Ulasov I, Breidenbach M, Kataram M, Contreras JL, Krumdieck C, Yamamoto M, Rots MG, Haisma HJ, Alvarez RD, Mahasreshti PJ and Curiel DT . (2004). Clin. Cancer Res., 10, 8697–8703.
Kirn D, Martuza RL and Zwiebel J . (2001). Nat. Med., 7, 781–787.
Koizumi N, Mizuguchi H, Utoguchi N, Watanabe Y and Hayakawa T . (2003). J. Gene Med., 5, 267–276.
Korn T, Nettelbeck DM, Volkel T, Muller R and Kontermann RE . (2004). J. Gene Med., 6, 642–651.
Korokhov N, Mikheeva G, Krendelshchikov A, Belousova N, Simonenko V, Krendelshchikova V, Pereboev A, Kotov A, Kotova O, Triozzi PL, Aldrich WA, Douglas JT, Lo KM, Banerjee PT, Gillies SD, Curiel DT and Krasnykh V . (2003). J. Virol., 77, 12931–12940.
Kraaij R, van Rijswijk AL, Oomen MH, Haisma HJ and Bangma CH . (2005). Prostate, 62, 253–259.
Krasnykh V, Belousova N, Korokhov N, Mikheeva G and Curiel DT . (2001). J. Virol., 75, 4176–4183.
Krasnykh V, Dmitriev I, Mikheeva G, Miller CR, Belousova N and Curiel DT . (1998). J. Virol., 72, 1844–1852.
Krasnykh VN, Mikheeva GV, Douglas JT and Curiel DT . (1996). J. Virol., 70, 6839–6846.
Kremer EJ . (2004). J. Gene Med., 6 (Suppl 1), S139–S151.
Kremer EJ, Boutin S, Chillon M and Danos O . (2000). J. Virol., 74, 505–512.
Kruyt FA and Curiel DT . (2002). Hum. Gene Ther., 13, 485–495.
Kurihara T, Brough DE, Kovesdi I and Kufe DW . (2000). J. Clin. Invest., 106, 763–771.
Lam JT, Kanerva A, Bauerschmitz GJ, Takayama K, Suzuki K, Yamamoto M, Bhoola SM, Liu B, Wang M, Barnes MN, Alvarez RD, Siegal GP, Curiel DT and Hemminki A . (2004). J. Gene Med., 6, 1333–1342.
Lamont JP, Nemunaitis J, Kuhn JA, Landers SA and McCarty TM . (2000). Ann. Surg. Oncol., 7, 588–592.
Lang FF, Bruner JM, Fuller GN, Aldape K, Prados MD, Chang S, Berger MS, McDermott MW, Kunwar SM, Junck LR, Chandler W, Zwiebel JA, Kaplan RS and Yung WK . (2003). J. Clin. Oncol., 21, 2508–2518.
Le LP, Everts M, Dmitriev IP, Davydova JG, Yamamoto M and Curiel DT . (2004). Mol. Imaging, 3, 105–116.
Lee H, Song JJ, Kim E, Yun CO, Choi J, Lee B, Kim J, Chang JW and Kim JH . (2001). Gene Therapy, 8, 268–273.
Lehmberg E, Traina JA, Chakel JA, Chang RJ, Parkman M, McCaman MT, Murakami PK, Lahidji V, Nelson JW, Hancock WS, Nestaas E and Pungor Jr E . (1999). J. Chromatogr. B Biomed. Sci. Appl., 732, 411–423.
Li D, Duan L, Freimuth P and O'Malley Jr W . (1999). Clin. Cancer Res., 5, 4175–4181.
Li J, Le LP, Sibley DA, Mathis JM and Curiel DT . (2005). Virology, 338, 247–258.
Liang Q, Nguyen K, Satyamurthy N, Barrio JR, Phelps ME, Gambhir SS and Herschman HR . (2002). Gene Therapy, 9, 1659–1666.
Lichty BD, Stojdl DF, Taylor RA, Miller L, Frenkel I, Atkins H and Bell JC . (2004). Hum. Gene Ther., 15, 821–831.
Liu R, Martuza RL and Rabkin SD . (2005a). Gene Therapy, 12, 647–654.
Liu R, Varghese S and Rabkin SD . (2005b). Cancer Res., 65, 1532–1540.
Louis N, Fender P, Barge A, Kitts P and Chroboczek J . (1994). J. Virol., 68, 4104–4106.
Lu W, Zheng S, Li XF, Huang JJ, Zheng X and Li Z . (2004). World J. Gastroenterol., 10, 3634–3638.
Lutz P, Rosa-Calatrava M and Kedinger C . (1997). J. Virol., 71, 5102–5109.
Magnusson MK, Hong SS, Boulanger P and Lindholm L . (2001). J. Virol., 75, 7280–7289.
Magnusson MK, Hong SS, Henning P, Boulanger P and Lindholm L . (2002). J. Gene Med., 4, 356–370.
Makower D, Rozenblit A, Kaufman H, Edelman M, Lane ME, Zwiebel J, Haynes H and Wadler S . (2003). Clin. Cancer Res., 9, 693–702.
Marusyk RG . (1972). Can. J. Microbiol., 18, 817–823.
Marusyk RG and Hammarskjold ML . (1972). Microbios., 5, 259–264.
Marusyk RG, Norrby E and Lundqvist U . (1970). J. Virol., 5, 507–512.
Marusyk RG and Yamamoto T . (1971). Can. J. Microbiol., 17, 151–155.
Mastrangeli A, Harvey BG, Yao J, Wolff G, Kovesdi I, Crystal RG and Falck-Pedersen E . (1996). Hum. Gene Ther., 7, 79–87.
McDonald D, Stockwin L, Matzow T, Blair Zajdel ME and Blair GE . (1999). Gene Therapy, 6, 1512–1519.
Mercier GT, Campbell JA, Chappell JD, Stehle T, Dermody TS and Barry MA . (2004). Proc. Natl. Acad. Sci. USA, 101, 6188–6193.
Meulenbroek RA, Sargent KL, Lunde J, Jasmin BJ and Parks RJ . (2004). Mol. Ther., 9, 617–624.
Michael SI, Hong JS, Curiel DT and Engler JA . (1995). Gene Therapy, 2, 660–668.
Miller CR, Buchsbaum DJ, Reynolds PN, Douglas JT, Gillespie GY, Mayo MS, Raben D and Curiel DT . (1998). Cancer Res., 58, 5738–5748.
Miyazawa N, Leopold PL, Hackett NR, Ferris B, Worgall S, Falck-Pedersen E and Crystal RG . (1999). J. Virol., 73, 6056–6065.
Mizuguchi H, Koizumi N, Hosono T, Utoguchi N, Watanabe Y, Kay MA and Hayakawa T . (2001). Gene Therapy, 8, 730–735.
Mulvihill S, Warren R, Venook A, Adler A, Randlev B, Heise C and Kirn D . (2001). Gene Therapy, 8, 308–315.
Muster T, Rajtarova J, Sachet M, Unger H, Fleischhacker R, Romirer I, Grassauer A, Url A, Garcia-Sastre A, Wolff K, Pehamberger H and Bergmann M . (2004). Int. J. Cancer, 110, 15–21.
Myers R, Greiner S, Harvey M, Soeffker D, Frenzke M, Abraham K, Shaw A, Rozenblatt S, Federspiel MJ, Russell SJ and Peng KW . (2005). Cancer Gene Ther., 12, 593–599.
Nakamura T, Sato K and Hamada H . (2003). J. Virol., 77, 2512–2521.
Nemunaitis J, Khuri F, Ganly I, Arseneau J, Posner M, Vokes E, Kuhn J, McCarty T, Landers S, Blackburn A, Romel L, Randlev B, Kaye S and Kirn D . (2001). J. Clin. Oncol., 19, 289–298.
Nettelbeck DM, Rivera AA, Balague C, Alemany R and Curiel DT . (2002). Cancer Res., 62, 4663–4670.
Nicklin SA, Von Seggern DJ, Work LM, Pek DC, Dominiczak AF, Nemerow GR and Baker AH . (2001). Mol. Ther., 4, 534–542.
Nicol CG, Graham D, Miller WH, White SJ, Smith TA, Nicklin SA, Stevenson SC and Baker AH . (2004). Mol. Ther., 10, 344–354.
Nilson BH, Morling FJ, Cosset FL and Russell SJ . (1996). Gene Therapy, 3, 280–286.
Nilsson M, Ljungberg J, Richter J, Kiefer T, Magnusson M, Lieber A, Widegren B, Karlsson S and Fan X . (2004). J. Gene Med., 6, 631–641.
Norman KL, Hirasawa K, Yang AD, Shields MA and Lee PW . (2004). Proc. Natl. Acad. Sci. USA, 101, 11099–11104.
Noureddini SC, Krendelschchikov A, Simonenko V, Douglas JT, Curiel DT and Korokhov N . (2005). J. Virol. (in press).
Pagliaro LC, Keyhani A, Williams D, Woods D, Liu B, Perrotte P, Slaton JW, Merritt JA, Grossman HB and Dinney CP . (2003). J. Clin. Oncol., 21, 2247–2253.
Parikh NS, Currier MA, Mahller YY, Adams LC, Di Pasquale B, Collins MH and Cripe TP . (2005). Pediatr. Blood Cancer, 44, 469–478.
Peng KW, Facteau S, Wegman T, O'Kane D and Russell SJ . (2002). Nat. Med., 8, 527–531.
Penuelas I, Mazzolini G, Boan JF, Sangro B, Marti-Climent J, Ruiz M, Ruiz J, Satyamurthy N, Qian C, Barrio JR, Phelps ME, Richter JA, Gambhir SS and Prieto J . (2005). Gastroenterology, 128, 1787–1795.
Portella G, Scala S, Vitagliano D, Vecchio G and Fusco A . (2002). J. Clin. Endocrinol. Metab., 87, 2525–2531.
Qin M, Chen S, Yu T, Escuadro B, Sharma S and Batra RK . (2003). Clin. Cancer Res., 9, 4992–4999.
Raki M, Kanerva A, Ristimaki A, Desmond RA, Chen DT, Ranki T, Sarkioja M, Kangasniemi L and Hemminki A . (2005). Gene Therapy, 12, 1198–1205.
Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, Wilson JM and Batshaw ML . (2003). Mol. Genet. Metab., 80, 148–158.
Raykov Z, Balboni G, Aprahamian M and Rommelaere J . (2004). Int. J. Cancer, 109, 742–749.
Reid T, Galanis E, Abbruzzese J, Sze D, Andrews J, Romel L, Hatfield M, Rubin J and Kirn D . (2001). Gene Therapy, 8, 1618–1626.
Rein DT, Breidenbach M, Kirby TO, Han T, Siegal GP, Bauerschmitz GJ, Wang M, Nettelbeck DM, Tsuruta Y, Yamamoto M, Dall P, Hemminki A and Curiel DT . (2005). Clin. Cancer Res., 11, 1327–1335.
Reynolds PN, Zinn KR, Gavrilyuk VD, Balyasnikova IV, Rogers BE, Buchsbaum DJ, Wang MH, Miletich DJ, Grizzle WE, Douglas JT, Danilov SM and Curiel DT . (2000). Mol. Ther., 2, 562–578.
Rivera AA, Davydova J, Schierer S, Wang M, Krasnykh V, Yamamoto M, Curiel DT and Nettelbeck DM . (2004). Gene Therapy, 11, 1694–1702.
Roux P, Jeanteur P and Piechaczyk M . (1989). Proc. Natl. Acad. Sci. USA, 86, 9079–9083.
Ruigrok RW, Barge A, Albiges-Rizo C and Dayan S . (1990). J. Mol. Biol., 215, 589–596.
Sachs MD, Rauen KA, Ramamurthy M, Dodson JL, De Marzo AM, Putzi MJ, Schoenberg MP and Rodriguez R . (2002). Urology, 60, 531–536.
Sauthoff H, Pipiya T, Heitner S, Chen S, Norman RG, Rom WN and Hay JG . (2002). Hum. Gene Ther., 13, 1859–1871.
Schaack J . (2005). Viral. Immunol., 18, 79–88.
Schuler M, Herrmann R, De Greve JL, Stewart AK, Gatzemeier U, Stewart DJ, Laufman L, Gralla R, Kuball J, Buhl R, Heussel CP, Kommoss F, Perruchoud AP, Shepherd FA, Fritz MA, Horowitz JA, Huber C and Rochlitz C . (2001). J. Clin. Oncol., 19, 1750–1758.
Segerman A, Arnberg N, Erikson A, Lindman K and Wadell G . (2003a). J. Virol., 77, 1157–1162.
Segerman A, Atkinson JP, Marttila M, Dennerquist V, Wadell G and Arnberg N . (2003b). J. Virol., 77, 9183–9191.
Seshidhar Reddy P, Ganesh S, Limbach MP, Brann T, Pinkstaff A, Kaloss M, Kaleko M and Connelly S . (2003). Virology, 311, 384–393.
Shayakhmetov DM, Eberly AM, Li ZY and Lieber A . (2005a). J. Virol., 79, 1053–1061.
Shayakhmetov DM, Gaggar A, Ni S, Li ZY and Lieber A . (2005b). J. Virol., 79, 7478–7491.
Shayakhmetov DM, Li ZY, Ni S and Lieber A . (2004). J. Virol., 78, 5368–5381.
Shayakhmetov DM, Papayannopoulou T, Stamatoyannopoulos G and Lieber A . (2000). J. Virol., 74, 2567–2583.
Shi J, Zheng D, Liu Y, Sham MH, Tam P, Farzaneh F and Xu R . (2005). Cancer Res., 65, 1687–1692.
Shillitoe EJ and Pellenz C . (2005). Clin. Cancer Res., 11, 3109–3116.
Shinoura N, Sakurai S, Asai A, Kirino T and Hamada H . (2000). Jpn. J. Cancer Res., 91, 1028–1034.
Shinozaki K, Ebert O, Kournioti C, Tai YS and Woo SL . (2004). Mol. Ther., 9, 368–376.
Short JJ, Pereboev AV, Kawakami Y, Vasu C, Holterman MJ and Curiel DT . (2004). Virology, 322, 349–359.
Sinclair AM, Agrawal YP, Elbar E, Agrawal R, Ho AD and Levine F . (1997). Gene Therapy, 4, 918–927.
Sinkovics J and Horvath J . (1993). Intervirology, 36, 193–214.
Sirena D, Lilienfeld B, Eisenhut M, Kalin S, Boucke K, Beerli RR, Vogt L, Ruedl C, Bachmann MF, Greber UF and Hemmi S . (2004). J. Virol., 78, 4454–4462.
Soudais C, Boutin S, Hong SS, Chillon M, Danos O, Bergelson JM, Boulanger P and Kremer EJ . (2000). J. Virol., 74, 10639–10649.
Stevenson SC, Rollence M, White B, Weaver L and McClelland A . (1995). J. Virol., 69, 2850–2857.
Stewart PL, Burnett RM, Cyrklaff M and Fuller SD . (1991). Cell, 67, 145–154.
Stoff-Khalili MA, Rivera AA, Glasgow JN, Le LP, Stoff A, Everts M, Tsuruta Y, Kawakami Y, Bauerschmitz GJ, Mathis JM, Pereboeva L, Seigal GP, Dall P and Curiel DT . (2005). Gene Therapy, July 21 (Epub ahead of print).
Stone D, Ni S, Li ZY, Gaggar A, DiPaolo N, Feng Q, Sandig V and Lieber A . (2005). J. Virol., 79, 5090–5104.
Tao N, Gao GP, Parr M, Johnston J, Baradet T, Wilson JM, Barsoum J and Fawell SE . (2001). Mol. Ther., 3, 28–35.
Tekant Y, Davydova J, Ramirez PJ, Curiel DT, Vickers SM and Yamamoto M . (2005). Surgery, 137, 527–535.
Ternovoi VV, Le LP, Belousova N, Smith BF, Siegal GP and Curiel DT . (2005). J. Virol., 79, 1308–1311.
Tomko RP, Xu R and Philipson L . (1997). Proc. Natl. Acad. Sci. USA, 94, 3352–3356.
Toth K, Spencer JF, Tollefson AE, Kuppuswamy M, Doronin K, Lichtenstein DL, La Regina MC, Prince GA and Wold WS . (2005). Hum. Gene Ther., 16, 139–146.
Tseng JC, Hurtado A, Yee H, Levin B, Boivin C, Benet M, Blank SV, Pellicer A and Meruelo D . (2004a). Cancer Res., 64, 6684–6692.
Tseng JC, Levin B, Hurtado A, Yee H, Perez de Castro I, Jimenez M, Shamamian P, Jin R, Novick RP, Pellicer A and Meruelo D . (2004b). Nat. Biotechnol., 22, 70–77.
Uchino J, Takayama K, Harada A, Kawakami Y, Inoue H, Curiel DT and Nakanishi Y . (2005). Cancer Gene Ther., April 29 (Epub ahead of print).
Unno Y, Shino Y, Kondo F, Igarashi N, Wang G, Shimura R, Yamaguchi T, Asano T, Saisho H, Sekiya S and Shirasawa H . (2005). Clin. Cancer Res., 11, 4553–4560.
van Beusechem VW, van Rijswijk AL, van Es HH, Haisma HJ, Pinedo HM and Gerritsen WR . (2000). Gene Therapy, 7, 1940–1946.
van der Poel HG, Molenaar B, van Beusechem VW, Haisma HJ, Rodriguez R, Curiel DT and Gerritsen WR . (2002). J. Urol., 168, 266–272.
van Oostrum J and Burnett RM . (1985). J. Virol., 56, 439–448.
Vanderkwaak TJ, Wang M, Gomez-Navarro J, Rancourt C, Dmitriev I, Krasnykh V, Barnes M, Siegal GP, Alvarez R and Curiel DT . (1999). Gynecol. Oncol., 74, 227–234.
Vasey PA, Shulman LN, Campos S, Davis J, Gore M, Johnston S, Kirn DH, O'Neill V, Siddiqui N, Seiden MV and Kaye SB . (2002). J. Clin. Oncol., 20, 1562–1569.
Vellinga J, Rabelink MJ, Cramer SJ, van den Wollenberg DJ, Van der Meulen H, Leppard KN, Fallaux FJ and Hoeben RC . (2004). J. Virol., 78, 3470–3479.
Vellinga J, Van der Heijdt S and Hoeben RC . (2005). J. Gen. Virol., 86, 1581–1588.
Vigne E, Mahfouz I, Dedieu JF, Brie A, Perricaudet M and Yeh P . (1999). J. Virol., 73, 5156–5161.
Voeks D, Martiniello-Wilks R, Madden V, Smith K, Bennetts E, Both GW and Russell PJ . (2002). Gene Therapy, 9, 759–768.
Vollmer CM, Ribas A, Butterfield LH, Dissette VB, Andrews KJ, Eilber FC, Montejo LD, Chen AY, Hu B, Glaspy JA, McBride WH and Economou JS . (1999). Cancer Res., 59, 4369–4374.
Volpers C, Thirion C, Biermann V, Hussmann S, Kewes H, Dunant P, von der Mark H, Herrmann A, Kochanek S and Lochmuller H . (2003). J. Virol., 77, 2093–2104.
Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN and Edwards BK . (2003). J. Natl. Cancer Inst., 95, 1276–1299.
Wesseling JG, Bosma PJ, Krasnykh V, Kashentseva EA, Blackwell JL, Reynolds PN, Li H, Parameshwar M, Vickers SM, Jaffee EM, Huibregtse K, Curiel DT and Dmitriev I . (2001). Gene Therapy, 8, 969–976.
Wickham TJ, Mathias P, Cheresh DA and Nemerow GR . (1993). Cell, 73, 309–319.
Wickham TJ, Roelvink PW, Brough DE and Kovesdi I . (1996). Nat. Biotechnol., 14, 1570–1573.
Wickham TJ, Tzeng E, Shears II L, Roelvink PW, Li Y, Lee GM, Brough DE, Lizonova A and Kovesdi I . (1997). J. Virol., 71, 8221–8229.
Witlox AM, Van Beusechem VW, Molenaar B, Bras H, Schaap GR, Alemany R, Curiel DT, Pinedo HM, Wuisman PI and Gerritsen WR . (2004). Clin. Cancer Res., 10, 61–67.
Wolf JK, Bodurka DC, Gano JB, Deavers M, Ramondetta L, Ramirez PT, Levenback C and Gershenson DM . (2004). Gynecol. Oncol., 94, 442–448.
Wu E, Fernandez J, Fleck SK, Von Seggern DJ, Huang S and Nemerow GR . (2001). Virology, 279, 78–89.
Wu E, Trauger SA, Pache L, Mullen TM, von Seggern DJ, Siuzdak G and Nemerow GR . (2004a). J. Virol., 78, 3897–3905.
Wu H, Han T, Belousova N, Krasnykh V, Kashentseva E, Dmitriev I, Kataram M, Mahasreshti PJ and Curiel DT . (2005). J. Virol., 79, 3382–3390.
Wu H, Han T, Lam JT, Leath CA, Dmitriev I, Kashentseva E, Barnes MN, Alvarez RD and Curiel DT . (2004b). Gene Therapy, 11, 874–878.
Wu H, Seki T, Dmitriev I, Uil T, Kashentseva E, Han T and Curiel DT . (2002). Hum. Gene Ther., 13, 1647–1653.
Xia H, Anderson B, Mao Q and Davidson BL . (2000). J. Virol., 74, 11359–11366.
Yamamoto M, Davydova J, Wang M, Siegal GP, Krasnykh V, Vickers SM and Curiel DT . (2003). Gastroenterology, 125, 1203–1218.
Yang M, Baranov E, Moossa AR, Penman S and Hoffman RM . (2000). Proc. Natl. Acad. Sci. USA, 97, 12278–12282.
Yoshida Y, Sadata A, Zhang W, Saito K, Shinoura N and Hamada H . (1998). Hum. Gene Ther., 9, 2503–2515.
You Z, Fischer DC, Tong X, Hasenburg A, Aguilar-Cordova E and Kieback DG . (2001). Cancer Gene Ther., 8, 168–175.
Yun CO, Yoon AR, Yoo JY, Kim H, Kim M, Ha T, Kim GE, Kim H and Kim JH . (2005). Hum. Gene Ther., 16, 248–261.
Zabner J, Chillon M, Grunst T, Moninger TO, Davidson BL, Gregory R and Armentano D . (1999). J. Virol., 73, 8689–8695.
Zakhartchouk A, Zhou Y and Tikoo SK . (2003). Virology, 313, 377–386.
Zeimet AG and Marth C . (2003). Lancet Oncol., 4, 415–422.
Zhang J, Frolov I and Russell SJ . (2004a). J. Gene Med., 6, 1082–1091.
Zhang J, Frolov I and Russell SJ . (2004b). J. Gene Med., 6, 1082–1091.
Zhang L, Gomis S and Tikoo SK . (2005). Virus Res., 110, 169–176.
Zhang LQ, Mei YF and Wadell G . (2003). J. Gen. Virol., 84, 687–695.
Zhu ZB, Makhija SK, Lu B, Wang M, Rivera AA, Kim-Park S, Ulasov IV, Zhou F, Alvarez RD, Siegal GP and Curiel DT . (2005). Int. J. Oncol., 27, 237–246.
Zhu ZB, Makhija SK, Lu B, Wang M, Rivera AA, Preuss M, Zhou F, Siegal GP, Alvarez RD and Curiel DT . (2004). Virology, 325, 116–128.
Zinn KR, Buchsbaum DJ, Chaudhuri TR, Mountz JM, Grizzle WE and Rogers BE . (2000). J. Nucl. Med., 41, 887–895.
Acknowledgements
This work was supported by NIH grant P50 CA86306 and DOD award W81XWH-04-1-0025. We acknowledge support from the Louisiana Gene Therapy Research Consortium, Inc.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mathis, J., Stoff-Khalili, M. & Curiel, D. Oncolytic adenoviruses – selective retargeting to tumor cells. Oncogene 24, 7775–7791 (2005). https://doi.org/10.1038/sj.onc.1209044
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209044
Keywords
This article is cited by
-
Oncolytic virotherapy: basic principles, recent advances and future directions
Signal Transduction and Targeted Therapy (2023)
-
Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer
Cancer Gene Therapy (2021)
-
Lister strain vaccinia virus with thymidine kinase gene deletion is a tractable platform for development of a new generation of oncolytic virus
Gene Therapy (2015)
-
Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein
Molecular Therapy - Oncolytics (2015)
-
Potent antitumor activity of oncolytic adenovirus-mediated SOCS1 for hepatocellular carcinoma
Gene Therapy (2013)
